Ideas to Action:

Independent research for global prosperity

CGD Policy Blogs


Perverse Incentives for South African AIDS Patients

The Wall Street Journal (subscription required) covered the increasing - and disturbing - phenomenon of South African AIDS patients who deliberately discontinue their free antiretroviral treatment in order to qualify for government-funded disability payments, which typically depend on a dangerously low CD4 count.

Inequality and HIV/AIDS

A recent article in the Toronto Globe and Mail detailed how astronomical inflation rates and the lack of foreign currency in Zimbabwe are undermining the delivery of and adherence to anti-retroviral therapy among HIV/AIDS patients.

World Health Day 2006

When the World Health Organization was launched in 1948, the First World Health Assembly established an annual World Health Day to "raise global awareness of a specific health theme to highlight a priority area of concern for the World Health Organization" and form the basis for a long-term advocacy program; since 1950, this has fallen on each April 7th. Over the past 10 years, the different themes have included:

The Commission on Intellectual Property Rights, Innovation and Public Health

The Commission on Intellectual Property Rights, Innovation and Public Health has published its report.

It analyzes the relationships between intellectual property rights, innovation and public health. It makes recommendations aimed to promote innovation (i.e. new diagnostics, vaccines and medicines) relevant to the needs of sick people in developing countries, and the accessibility of health-care products in developing countries.

Moving Upstream: Gates Funds PATH Pneumo Project

The Bill & Melinda Gates Foundation has made a $75 grant to PATH to develop low-cost vaccines for pneumococcal disease. As reported in the Seattle Post Intelligencer:

The goal of the PATH project is to explore a new approach that would stimulate immunity using basic proteins commonly found on the surface membranes of all pneumococcal serotypes.